Brendan Kelly
Fondateur chez A2a Pharmaceuticals, Inc.
Profil
Brendan is a Vice President at Lightstone Ventures evaluating opportunities in the biopharmaceutical sector.
Brendan has a background in medicinal chemistry and computational drug discovery research, and life sciences strategy.
Prior to Lightstone, Brendan was Director of New Product Planning at Q32 Bio, where he helped to define value propositions and commercial strategy for the company’s lead assets and discovery platform.
Brendan was previously a life sciences strategy consultant at L.E.K.
Consulting, working on projects across therapeutic areas, modalities and technologies, including pipeline optimization, go-to-market strategies, BD and M&A due diligence.
Brendan’s research at Stanford Computer Science, University of Toronto and Trinity College Dublin focused on computational methods of small molecule drug discovery for oncology and neuroscience targets.
With his background in research and strategy, Brendan is keenly Interested in the intersection of innovative science, company formation and strategy, particularly in the pursuit of new therapeutics for patients in need.
Postes actifs de Brendan Kelly
| Sociétés | Poste | Début |
|---|---|---|
A2a Pharmaceuticals, Inc.
 A2a Pharmaceuticals, Inc. Packaged SoftwareTechnology Services A2a Pharmaceuticals, Inc. develops proprietary computational systems and new therapeutics that serve highly unmet patient needs. The company was founded by Edward Painetr, Sridhar Wempati, Brendan Kelly, and Matthew Welsch and is headquartered in New York, NY. | Fondateur | - |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 01/11/2021 |
Anciens postes connus de Brendan Kelly
| Sociétés | Poste | Fin |
|---|---|---|
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/11/2021 |
OS Fund LLC
 OS Fund LLC Investment ManagersFinance OS Fund LLC (OS Fund) is a venture capital firm founded in 2014 by Bryan Johnson and Jeff Klunzinger. The firm is headquartered in Chicago, Illinois. | Consultant / Advisor | 01/11/2021 |
Formation de Brendan Kelly
| Trinity College Dublin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
A2a Pharmaceuticals, Inc.
A2a Pharmaceuticals, Inc. Packaged SoftwareTechnology Services A2a Pharmaceuticals, Inc. develops proprietary computational systems and new therapeutics that serve highly unmet patient needs. The company was founded by Edward Painetr, Sridhar Wempati, Brendan Kelly, and Matthew Welsch and is headquartered in New York, NY. | Technology Services |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Health Technology |
OS Fund LLC
OS Fund LLC Investment ManagersFinance OS Fund LLC (OS Fund) is a venture capital firm founded in 2014 by Bryan Johnson and Jeff Klunzinger. The firm is headquartered in Chicago, Illinois. | Finance |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Finance |